ConductScience.org, home

Paper29376136

Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort.

Nishioka ST and 4 others. Hepatoma Res, 2018. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort. Papers, record 29376136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29376136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort.
PubMed
Journal
Hepatoma Res
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.6
iCite
Revised in PubMed
2020-09-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nishioka STScott T
2Sato MMMiles M
3Wong LLLinda L
4Tiirikainen MMaarit
5Kwee SASandi A

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA071789NCI NIH HHSUnited StatesP30CA071789PubMed and NIHNIH RePORTER
R01 CA161209NCI NIH HHSUnited StatesR01CA161209PubMed and NIHNIH RePORTER
U54 MD007584NIMHD NIH HHSUnited StatesU54MD007584PubMed and NIHNIH RePORTER

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125220842Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.Int J Cancer2015https://conductscience.org/library/papers/25220842PubMed
216199517Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/16199517PubMed
319362088Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.Gastroenterology2009https://conductscience.org/library/papers/19362088PubMed
426213370Heterogeneity of liver cancer and personalized therapy.Cancer Lett2016https://conductscience.org/library/papers/26213370PubMed
524832180Low alpha-fetoprotein HCC and the role of GGTP.Int J Biol Markers2014https://conductscience.org/library/papers/24832180PubMed
618316609EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.Cancer Res2008https://conductscience.org/library/papers/18316609PubMed
717187432Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.Hepatology2007https://conductscience.org/library/papers/17187432PubMed
828499413Ranking metrics in gene set enrichment analysis: do they matter?BMC Bioinformatics2017https://conductscience.org/library/papers/28499413PubMed
926617981Molecular classification of hepatocellular carcinoma: potential therapeutic implications.Hepat Oncol2015https://conductscience.org/library/papers/26617981PubMed
1027732875Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma.Clin Chim Acta2016https://conductscience.org/library/papers/27732875PubMed
1126058462Clinicopathological indices to predict hepatocellular carcinoma molecular classification.Liver Int2016https://conductscience.org/library/papers/26058462PubMed
1220503898Hepatocellular cancer: risk factors and survival in Pacific Islanders compared to Caucasians in Hawaii.Ethn Dis2010https://conductscience.org/library/papers/20503898PubMed
1326546044Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib.Cancer Lett2016https://conductscience.org/library/papers/26546044PubMed
1411799067E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints.Genes Dev2002https://conductscience.org/library/papers/11799067PubMed
1518701503Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.Cancer Res2008https://conductscience.org/library/papers/18701503PubMed
1626995632Personalized therapy for hepatocellular carcinoma: Where are we now?Cancer Treat Rev2016https://conductscience.org/library/papers/26995632PubMed
1715349906Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.Hepatology2004https://conductscience.org/library/papers/15349906PubMed
1826213619Personalized management of hepatocellular carcinoma based on molecular information: future prospects.Clin Liver Dis (Hoboken)2015https://conductscience.org/library/papers/26213619PubMed
1925362482Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.Nat Genet2014https://conductscience.org/library/papers/25362482PubMed
2018505921Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases.Mol Cancer Res2008https://conductscience.org/library/papers/18505921PubMed

See all 35 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
35978665Second-line treatment of advanced hepatocellular carcinoma: Time for more individualized treatment options?World J Hepatol2022https://conductscience.org/library/papers/35978665PubMed
35699406The advanced development of molecular targeted therapy for hepatocellular carcinoma.Cancer Biol Med2022https://conductscience.org/library/papers/35699406PubMed
35360522R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation.JHEP Rep2022https://conductscience.org/library/papers/35360522PubMed
35052777Autoantibody to GNAS in Early Detection of Hepatocellular Carcinoma: A Large-Scale Sample Study Combined with Verification in Serial Sera from HCC Patients.Biomedicines2022https://conductscience.org/library/papers/35052777PubMed
35002508The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?Int J Biol Sci2022https://conductscience.org/library/papers/35002508PubMed
34484865Integrated analysis of the rhesus monkey liver transcriptome during development and human primary HCC AFP-related gene expression.Mol Ther Nucleic Acids2021https://conductscience.org/library/papers/34484865PubMed
33748017Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml).J Hepatocell Carcinoma2021https://conductscience.org/library/papers/33748017PubMed
33290597Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine.Cancer Commun (Lond)2020https://conductscience.org/library/papers/33290597PubMed
32374744Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.PLoS One2020https://conductscience.org/library/papers/32374744PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
EPCAM4072PubTator's text mininghttps://conductscience.org/library/genes/4072NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
TENM110178PubTator's text mininghttps://conductscience.org/library/genes/10178NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29376136

GET https://conductscience.org/api/papers/v1/29376136/references?page=2